Sunitha K. Rajaram
FDA investigator
Appears on 2 documents from 2021 to 2024, mostly at sites in California. Most often cites management responsibility (21 CFR 820.20(a)).
- 2
- Documents on file
- 6.0
- Observations per 483
- 2021
- First seen
- 2024
- Most recent
What they cite most
From 12 observations- 21 CFR 820.20(a)Management responsibility2
- 21 CFR 211.84(d)(1)Testing and approval or rejection of components, drug product containers, and closures1
- 21 CFR 803.17What are the requirements for developing, maintaining, and implementing written MDR procedures that apply to me?1
- 21 CFR 820.100(a)Corrective and preventive action1
- 21 CFR 820.160(a)Distribution1
- 21 CFR 820.198(a)Complaint files1
Activity by year
2021: 1, 2024: 1
Where
California 1 · Washington 1
Often inspects with
Is Sunitha K. Rajaram coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2024-05-03 | 483 BloodworksMay 3, 2024 · Seattle, Washington | Seattle, Washington | 1 | |
| 2021-04-09 | 483 INNOVA MEDICAL GROUP, INCApr 9, 2021 · Pasadena, California | Pasadena, California | 11 |
About this profile
What does Sunitha K. Rajaram inspect?
Sunitha K. Rajaram appears on 2 documents on file covering 2 sites, mostly in California.
What do they cite most often?
21 CFR 820.20(a) (management responsibility), followed by 21 CFR 211.84(d)(1) and 21 CFR 803.17.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Sunitha K. Rajaram is dated May 3, 2024.